Swiss heritage
Global health

Trusted by patients and doctors in over 70 countries.

We develop world-class treatments for Musculoskeletal Disorders, Ophthalmology and Neurology – blending Swiss precision with a family-driven commitment to care, quality and safety.

Learn more about our expertise

Therapeutic areas

Musculoskeletal

At the heart of our musculoskeletal expertise lies a singular mission: to restore mobility and quality of life. From the early management of tendinopathies to the relief of osteoarthritis pain, our solutions are built around the potential of hyaluronic acid – a naturally occurring molecule essential to joint and tissue health.¹

Musculoskeletal

Explore

Ophthalmology

We are dedicated to improving ocular comfort and eye health. For over twenty five years, our work has focused on supporting patients with dry eye disease and assisting surgeons. Our formulations are mostly based on sodium hyaluronate technology, designed to protect the ocular surface, reduce discomfort, and enhance visual outcomes in both daily care and surgical settings.^2,3

Ophthalmology

Explore

Sports medicine

From overuse strains to acute injuries, our focus is on helping people return to motion. We research evidence-based solutions rooted in musculoskeletal science, such as hyaluronic acid, to support tissue repair and restore function for athletes and active individuals.⁴

Sports medicine

Explore

Neurology

For over two decades, TRB has advanced research in neurological and neurodegenerative disorders such as Parkinson’s disease and stroke. Our long – standing work with GM1 ganglioside focuses on its neuroprotective and restorative properties,^5–7 driving continued innovation and collaboration in the field.

Neurology

Explore

Musculoskeletal

Explore

Our expertise

Close-up of a gloved hand using tweezers to handle green plant leaves in a petri dish.

Diacerein

Supporting joint health by targeting inflammation.

Diacerein targets inflammation by inhibiting interleukin-1 (IL-1), a key mediator in osteoarthritis progression. In addition to pain relief, it may slow structural changes in the joint. Our work with diacerein reflects a commitment to disease-modifying strategies in musculoskeletal care.

Find out more

Close-up of water droplets on a surface with varying sizes and shapes

Hyaluronic acid

The unique molecule at the heart of TRB's products.

Hyaluronic acid is a naturally occurring substance essential for maintaining hydration and tissue integrity in the eyes, skin, and joints. It is a vital component for lubrication and is known to support tissue function.⁸ At TRB, we have developed deep expertise in pharmaceutical-grade sodium hyaluronate. Our research focuses on its applications in musculoskeletal health and ophthalmology.

Find out more

Molecular structure with blue and red spheres representing atoms

GM1 Ganglioside

Supporting vital neuronal functions through protection, modulation, and repair.

GM1 ganglioside is a naturally occurring lipid found in high concentrations in the nervous system. It is known to be essential for supporting healthy nerve cell function, communication, and protection. ⁹ TRB has long-standing experience in the research and development of GM1. Our scientific focus is on its potential neuroprotective and restorative properties for applications in complex neurodegenerative conditions.

Find out more

Discover our brands

Our products help improve patient outcomes in our key focus areas, supported by clinical evidence and stringent Swiss quality standards.

About TRB

45+ Years in operation

70+ Countries served

1100+ Employees

Discover who we are

Inside our production sites

Swissmedic-authorised and GMP-qualified production site in Vouvry, Switzerland, combining hyaluronic acid processing, ganglioside extraction, and an integrated R&D unit.

Explore our global production sites

Modern building with large glass windows and wooden exterior

Exterior view of TRB building with modern architecture and landscaped garden.

Exterior view of TRB building with large windows and greenery

Person working at a desk with computer monitors in an office setting

Careers at TRB

Join us and be a part of developing healthcare worldwide, for future generations to come.

Work with us

Newsroom

Congress – Prague – May 20, 2026

We look forward to meeting you at the ESSKA 2026 conference in Prague.

Congress – Milan – June 18, 2026

Meet us at the EuDEC in Milan!

References

Papakonstantinou E, Roth M, Karakiulakis G. Hyaluronic acid: A key molecule in skin aging. Dermatoendocrinol. 2012;4(3):253-258.
Nguyen J, Werner L. (2017). Intraocular lenses for cataract surgery. In: Kolb H, Fernandez E, Nelson R, editors. Webvision: The Organization of the Retina and Visual System. Salt Lake City, UT: University of Utah Health Sciences Center.
Belda JI, Artola A, García-Manzanares MD, et al. Hyaluronic acid combined with mannitol to improve protection against free-radical endothelial damage: experimental model. J Cataract Refract Surg. 2005;31(6):1213-8.
Iaconisi GN, Gallo N, Caforio L, et al. Clinical and Biochemical Implications of Hyaluronic Acid in Musculoskeletal Rehabilitation: A Comprehensive Review. Journal of Personalized Medicine. 2023;13:1647.
Yanagisawa K. GM1 ganglioside and Alzheimer’s disease. Glycoconj J. 2015;32(3-4):105-12.
Schneider JS, Gollomp SM, Sendek S, et al. A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson’s disease patients. J Neurol Sci. 2013;324(1-2):140-8.
Alpaugh M, Galleguillos D, Forero J, et al. Disease-modifying effects of ganglioside GM1 in Huntington’s disease models. EMBO Mol Med. 2017;9(11):1537-1557.
Pavelka K, Bruyère O, Cooper C, et al. Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO. Drugs Aging. 2016;33(2):75-85.
Geisler FH, Dorsey FC, Coleman WP. Recovery of motor function after spinal-cord injury: a randomized, placebo-controlled trial with GM-1 ganglioside. N Engl J Med. 1991;324(26):1829-1838.

Swiss heritageGlobal health